MedPath

Extracorporeal Shockwave on Abdominal Adiposity and Lipid Profile

Not Applicable
Completed
Conditions
Obesity, Abdominal
Interventions
Other: Extracorporeal Shockwave therapy
Other: Balanced low-calorie diet
Registration Number
NCT06290674
Lead Sponsor
Cairo University
Brief Summary

Almost postmenopausal women store significant extra visceral adipose tissue with unexplained mechanism, yet. Postmenopausal obese women with excess abdominal obesity have raised metabolic risk of numerous cardiovascular diseases, which negatively influence health policy concern. Therefore, actual need to recommend non-invasive approach that cover this lack of quantitative knowledge in clinical management of obese postmenopausal women.

Detailed Description

Postmenopausal women are usually troubled by increasing weight and waist circumference caused by obesity and androcidal fat redistribution. Abdominal adiposity, defined as a waist circumference ≥88cm in women, measured in the upright position, plus significant elevated lipid profile values. In postmenopausal women, a higher level of physical activity was associated with a more optimal body composition, including lower adiposity and higher lean mass. Management of abdominal obesity involves different techniques i.e., dietary management, exercise therapy, even lifestyle management, and pharmacological management, and surgical interventions. Extracorporeal shockwave provides cavitation phenomena that may facilitate better management of abdominal obesity. Thus, current study will be conducted to investigate effect of extracorporeal shockwave on abdominal adiposity and lipid profile in obese post-menopausal women.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • Their age range 45-60 years old.
  • Their body mass index range 30-35 kg/m square.
  • Only, obese postmenopausal women with at least one year after stoppage of menses.
Read More
Exclusion Criteria
  • Receiving pharmacological treatment.
  • Receiving any form of electrotherapy.
  • Whom with metabolic, hematological or renal dysfunction.
  • Whom have dermatological or cardiovascular or respiratory, digestive or rheumatic disorders.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Study Group (A) (ESWT)Extracorporeal Shockwave therapy30 participants will receive Extracorporeal Shockwave (one session per week for 6 weeks), in addition to a balanced low-calorie diet (1500 k/cal for 6 weeks).
Study Group (A) (ESWT)Balanced low-calorie diet30 participants will receive Extracorporeal Shockwave (one session per week for 6 weeks), in addition to a balanced low-calorie diet (1500 k/cal for 6 weeks).
Control Group (B)Balanced low-calorie diet30 participant will receive Balanced low-calorie diet (1500 k/cal for 6 weeks), only.
Primary Outcome Measures
NameTimeMethod
Waist/ hip ratioPretreatment and Posttreatment of six weeks study protocol.

anthropometric outcome measure for abdominal adiposity

Skin fold caliperPretreatment and Posttreatment of six weeks study protocol.

subcutaneous fat outcome measure

Secondary Outcome Measures
NameTimeMethod
Lipid profilePretreatment and Posttreatment of six weeks study protocol.

Low-density lipoprotein, High-density lipoprotein, and triglyceride laboratory outcome measures.

Trial Locations

Locations (1)

Helwan General Hospital

🇪🇬

Cairo, Helwan, Cairo Governate, Egypt

© Copyright 2025. All Rights Reserved by MedPath